Beam Therapeutics Inc. - COM (BEAM)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
78.9M
Holdings value Q3 2024
$1.93B
Value change Q3 2024
+$32.1M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
214
Number of buys Q3 2024
94
Number of sells Q3 2024
-85
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 78.9M $1.93B +$32.1M $24.50 215
2024 Q2 77.5M $1.82B +$145M $23.43 209
2024 Q1 70M $2.31B +$41.6M $33.04 218
2023 Q4 68.9M $1.88B +$54.7M $27.22 185
2023 Q3 67.1M $1.61B +$62.6M $24.05 189
2023 Q2 64.2M $2.05B +$124M $31.93 190
2023 Q1 60.3M $1.85B +$135M $30.62 203
2022 Q4 55.8M $2.18B +$42.4M $39.11 203
2022 Q3 54.5M $2.6B -$7.41M $47.64 213
2022 Q2 54.7M $2.09B +$193M $38.71 188
2022 Q1 49.2M $2.82B +$202M $57.30 230
2021 Q4 45.5M $3.63B -$38.9M $79.69 224
2021 Q3 45.2M $3.93B -$44.6M $87.01 221
2021 Q2 45.5M $5.85B +$343M $128.71 225
2021 Q1 43M $3.44B +$479M $80.04 204
2020 Q4 36.9M $3.01B +$631M $81.64 151
2020 Q3 29.5M $727M +$39.6M $24.62 84
2020 Q2 27.7M $776M +$34.1M $28.00 70
2020 Q1 26.9M $484M +$484M $18.00 60